Induced pluripotent stem cells, also called artificially induced pluripotent stem cells, often referred to as iPS cells, are pluripotent stem cells formed by dedifferentiation of mammalian adult cells by transfer of transcription factors and other means. It was first developed by Japanese scholar Shinya Yamanaka The research team discovered in 2006. Shinya Yamanaka's team used mouse cells as experimental materials when publishing the iPS induction technology. In 2007, researchers proved that iPS induction technology can be applied to human cells.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Induced Pluripotent Stem Cells industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
Market Segment by Product Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Finally, the report provides detailed profile and data information analysis of leading company.
Fujifilm Holding Corporation (CDI)
ReproCELL
Astellas Pharma Inc
Ncardia
Cell Inspire Biotechnology
Sumitomo Dainippon Pharma
Pluricell Biotech
Fate Therapeutics, Inc
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Induced Pluripotent Stem Cells consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Induced Pluripotent Stem Cells market by identifying its various subsegments.
3.Focuses on the key global Induced Pluripotent Stem Cells manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Induced Pluripotent Stem Cells with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Induced Pluripotent Stem Cells submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Induced Pluripotent Stem Cells Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Induced Pluripotent Stem Cells Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Induced Pluripotent Stem Cells Segment by Type
2.1.1 Human iPSCs
2.1.2 Mouse iPSCs
2.1.3 Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
2.2 Market Analysis by Application
2.2.1 Academic Research
2.2.2 Drug Development and Discovery
2.2.3 Toxicity Screening
2.2.4 Regenerative Medicine
2.3 Global Induced Pluripotent Stem Cells Market Comparison by Regions (2017-2027)
2.3.1 Global Induced Pluripotent Stem Cells Market Size (2017-2027)
2.3.2 North America Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.3 Europe Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.4 Asia-pacific Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.5 South America Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Induced Pluripotent Stem Cells Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Induced Pluripotent Stem Cells Industry Impact
2.5.1 Induced Pluripotent Stem Cells Business Impact Assessment - Covid-19
2.5.2 Market Trends and Induced Pluripotent Stem Cells Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Induced Pluripotent Stem Cells Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Induced Pluripotent Stem Cells Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Induced Pluripotent Stem Cells Manufacturer Market Share
3.5 Top 10 Induced Pluripotent Stem Cells Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
3.7 Key Manufacturers Induced Pluripotent Stem Cells Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Induced Pluripotent Stem Cells Industry Key Manufacturers
4.1 Fujifilm Holding Corporation (CDI)
4.1.1 Company Details
4.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Fujifilm Holding Corporation (CDI) News
4.2 ReproCELL
4.2.1 Company Details
4.2.2 ReproCELL Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.2.3 ReproCELL Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 ReproCELL News
4.3 Astellas Pharma Inc
4.3.1 Company Details
4.3.2 Astellas Pharma Inc Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.3.3 Astellas Pharma Inc Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Astellas Pharma Inc News
4.4 Ncardia
4.4.1 Company Details
4.4.2 Ncardia Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.4.3 Ncardia Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Ncardia News
4.5 Cell Inspire Biotechnology
4.5.1 Company Details
4.5.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.5.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Cell Inspire Biotechnology News
4.6 Sumitomo Dainippon Pharma
4.6.1 Company Details
4.6.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.6.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Sumitomo Dainippon Pharma News
4.7 Pluricell Biotech
4.7.1 Company Details
4.7.2 Pluricell Biotech Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.7.3 Pluricell Biotech Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Pluricell Biotech News
4.8 Fate Therapeutics, Inc
4.8.1 Company Details
4.8.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells Product Introduction, Application and Specification
4.8.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Fate Therapeutics, Inc News
5 Global Induced Pluripotent Stem Cells Sales Categorized by Regions
5.1 Global Induced Pluripotent Stem Cells Revenue, Sales and Market Share by Regions
5.1.1 Global Induced Pluripotent Stem Cells Sales and Market Share by Regions (2017-2022)
5.1.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Regions (2017-2022)
5.2 North America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
5.3 Europe Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
5.5 South America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
6 North America Induced Pluripotent Stem Cells Market Size Categorized by Countries
6.1 North America Induced Pluripotent Stem Cells Sales, Revenue and Market Share by Countries
6.1.1 North America Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
6.1.2 North America Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
6.1.3 United States Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
6.1.4 Canada Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
6.1.5 Mexico Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
6.2 North America Induced Pluripotent Stem Cells Revenue (Value) by Manufacturers
6.3 North America Induced Pluripotent Stem Cells Sales and Market Share by Type (2017-2022)
6.4 North America Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
7 Europe Induced Pluripotent Stem Cells Market Size Categorized by Countries
7.1 Europe Induced Pluripotent Stem Cells Sales, Revenue and Market Share by Countries
7.1.1 Europe Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
7.1.3 Germany Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.1.4 UK Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.1.5 France Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.1.6 Russia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.1.7 Italy Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.1.8 Spain Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
7.2 Europe Induced Pluripotent Stem Cells Revenue (Value) by Manufacturers
7.3 Europe Induced Pluripotent Stem Cells Sales and Market Share by Type (2017-2022)
7.4 Europe Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
8 Asia-Pacific Induced Pluripotent Stem Cells Market Size Categorized by Countries
8.1 Asia-pacific Induced Pluripotent Stem Cells Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
8.1.3 China Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.1.4 South Korea Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.1.5 Japan Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.1.6 Australia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.1.7 India Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Induced Pluripotent Stem Cells Revenue (Value) by Manufacturers
8.3 Asia-pacific Induced Pluripotent Stem Cells Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
9 South America Induced Pluripotent Stem Cells Market Size Categorized by Countries
9.1 South America Induced Pluripotent Stem Cells Sales, Revenue and Market Share by Countries
9.1.1 South America Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
9.1.2 South America Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
9.1.3 Brazil Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
9.2 South America Induced Pluripotent Stem Cells Sales and Market Share by Type (2017-2022)
9.3 South America Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
10 Middle East and Africa Induced Pluripotent Stem Cells Market Size Categorized by Countries
10.1 Middle East and Africa Induced Pluripotent Stem Cells Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
10.1.3 GCC Countries Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
10.1.4 Turkey Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
10.1.5 Egypt Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
10.1.6 South America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Induced Pluripotent Stem Cells Sales and Market Share by Type
10.3 Middle East and Africa Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
11 Global Induced Pluripotent Stem Cells Market Segment by Type
11.1 Global Induced Pluripotent Stem Cells Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Induced Pluripotent Stem Cells Sales and Market Share by Type (2017-2022)
11.1.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Type (2017-2022)
11.2 Human iPSCs Sales Growth Rate and Price
11.2.1 Global Human iPSCs Sales Growth Rate (2017-2022)
11.2.2 Global Human iPSCs Price (2017-2022)
11.3 Mouse iPSCs Sales Growth Rate and Price
11.3.1 Global Mouse iPSCs Sales Growth Rate (2017-2022)
11.3.2 Global Mouse iPSCs Price (2017-2022)
11.4 Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate and Price
11.4.1 Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate (2017-2022)
11.4.2 Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Price (2017-2022)
12 Global Induced Pluripotent Stem Cells Market Segment by Application
12.1 Global Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
12.2 Academic Research Sales Growth Rate (2017-2022)
12.3 Drug Development and Discovery Sales Growth Rate (2017-2022)
12.4 Toxicity Screening Sales Growth Rate (2017-2022)
12.5 Regenerative Medicine Sales Growth Rate (2017-2022)
13 Global Induced Pluripotent Stem Cells Market Forecast
13.1 Global Induced Pluripotent Stem Cells Revenue, Sales and Growth Rate (2022-2027)
13.2 Induced Pluripotent Stem Cells Market Forecast by Regions (2022-2027)
13.2.1 North America Induced Pluripotent Stem Cells Market Forecast (2022-2027)
13.2.2 Europe Induced Pluripotent Stem Cells Market Forecast (2022-2027)
13.2.3 Asia-Pacific Induced Pluripotent Stem Cells Market Forecast (2022-2027)
13.2.4 South America Induced Pluripotent Stem Cells Market Forecast (2022-2027)
13.2.5 Middle East & Africa Induced Pluripotent Stem Cells Market Forecast (2022-2027)
13.3 Induced Pluripotent Stem Cells Market Forecast by Type (2022-2027)
13.3.1 Global Induced Pluripotent Stem Cells Sales Forecast by Type (2022-2027)
13.3.2 Global Induced Pluripotent Stem Cells Market Share Forecast by Type (2022-2027)
13.4 Induced Pluripotent Stem Cells Market Forecast by Application (2022-2027)
13.4.1 Global Induced Pluripotent Stem Cells Sales Forecast by Application (2022-2027)
13.4.2 Global Induced Pluripotent Stem Cells Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Induced Pluripotent Stem Cells Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Induced Pluripotent Stem Cells Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Induced Pluripotent Stem Cells
Figure Market Concentration Ratio and Market Maturity Analysis of Induced Pluripotent Stem Cells
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Induced Pluripotent Stem Cells Market Size by Type
Figure Global Market Share of Induced Pluripotent Stem Cells by Type in 2021
Figure Human iPSCs Picture
Figure Mouse iPSCs Picture
Figure Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Picture
Table Global Induced Pluripotent Stem Cells Market Size (Volume) by Application
Figure Academic Research Picture
Figure Drug Development and Discovery Picture
Figure Toxicity Screening Picture
Figure Regenerative Medicine Picture
Table Global Induced Pluripotent Stem Cells Comparison by Regions (M USD) 2017-2027
Figure Global Induced Pluripotent Stem Cells Market Size (Million US$) (2017-2027)
Figure North America Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Induced Pluripotent Stem Cells Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Induced Pluripotent Stem Cells Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Induced Pluripotent Stem Cells Sales by Manufacturer (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Manufacturer in 2021
Table Global Induced Pluripotent Stem Cells Revenue by Manufacturer (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Manufacturer in 2021
Table Global Induced Pluripotent Stem Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Induced Pluripotent Stem Cells Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Induced Pluripotent Stem Cells Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
Table Key Manufacturers Induced Pluripotent Stem Cells Product Type
Table Mergers & Acquisitions Planning
Table Fujifilm Holding Corporation (CDI) Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Fujifilm Holding Corporation (CDI)
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fujifilm Holding Corporation (CDI) 2017-2022
Table Fujifilm Holding Corporation (CDI) Main Business
Table Fujifilm Holding Corporation (CDI) Recent Development
Table ReproCELL Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of ReproCELL
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ReproCELL 2017-2022
Table ReproCELL Main Business
Table ReproCELL Recent Development
Table Astellas Pharma Inc Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Astellas Pharma Inc
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Astellas Pharma Inc 2017-2022
Table Astellas Pharma Inc Main Business
Table Astellas Pharma Inc Recent Development
Table Ncardia Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Ncardia
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ncardia 2017-2022
Table Ncardia Main Business
Table Ncardia Recent Development
Table Cell Inspire Biotechnology Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Cell Inspire Biotechnology
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cell Inspire Biotechnology 2017-2022
Table Cell Inspire Biotechnology Main Business
Table Cell Inspire Biotechnology Recent Development
Table Sumitomo Dainippon Pharma Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Sumitomo Dainippon Pharma
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sumitomo Dainippon Pharma 2017-2022
Table Sumitomo Dainippon Pharma Main Business
Table Sumitomo Dainippon Pharma Recent Development
Table Pluricell Biotech Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Pluricell Biotech
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pluricell Biotech 2017-2022
Table Pluricell Biotech Main Business
Table Pluricell Biotech Recent Development
Table Fate Therapeutics, Inc Company Profile
Table Induced Pluripotent Stem Cells Product Introduction, Application and Specification of Fate Therapeutics, Inc
Table Induced Pluripotent Stem Cells Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fate Therapeutics, Inc 2017-2022
Table Fate Therapeutics, Inc Main Business
Table Fate Therapeutics, Inc Recent Development
Figure Global Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Regions (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Regions in 2021
Table Global Induced Pluripotent Stem Cells Revenue by Regions (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Regions in 2021
Figure North America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Europe Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Asia-pacific Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure South America Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure North America Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table North America Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
Table North America Induced Pluripotent Stem Cells Sales Market Share by Countries (2017-2022)
Figure North America Induced Pluripotent Stem Cells Sales Market Share by Countries in 2021
Table North America Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
Table North America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2017-2022)
Figure North America Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2021
Figure United States Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Canada Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Mexico Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table North America Induced Pluripotent Stem Cells Revenue by Manufacturer (2021)
Figure North America Induced Pluripotent Stem Cells Revenue Market Share by Manufacturer in 2021
Table North America Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table North America Induced Pluripotent Stem Cells Sales Share by Type (2017-2022)
Table North America Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table North America Induced Pluripotent Stem Cells Sales Share by Application (2017-2022)
Figure Europe Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table Europe Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
Table Europe Induced Pluripotent Stem Cells Sales Market Share by Countries (2017-2022)
Figure Europe Induced Pluripotent Stem Cells Sales Market Share by Countries in 2021
Table Europe Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
Table Europe Induced Pluripotent Stem Cells Revenue Market Share by Countries (2017-2022)
Figure Europe Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2021
Figure Germany Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure UK Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure France Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Russia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Italy Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Spain Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table Europe Induced Pluripotent Stem Cells Revenue by Manufacturer (2021)
Figure Europe Induced Pluripotent Stem Cells Revenue Market Share by Manufacturer in 2021
Table Europe Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table Europe Induced Pluripotent Stem Cells Sales Share by Type (2017-2022)
Table Europe Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table Europe Induced Pluripotent Stem Cells Sales Share by Application (2017-2022)
Figure Asia-pacific Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Induced Pluripotent Stem Cells Sales Market Share by Countries in 2021
Table Asia-pacific Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2021
Figure China Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure South Korea Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Japan Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Australia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure India Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Southeast Asia Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Revenue by Manufacturer (2021)
Figure Asia-pacific Induced Pluripotent Stem Cells Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Sales Share by Type (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table Asia-pacific Induced Pluripotent Stem Cells Sales Share by Application (2017-2022)
Figure South America Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales Market Share by Countries (2017-2022)
Figure South America Induced Pluripotent Stem Cells Sales Market Share by Countries in 2019
Table South America Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
Table South America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2017-2022)
Figure South America Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure Brazil Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales Share by Type (2017-2022)
Table South America Induced Pluripotent Stem Cells Revenue by Type (2017-2022)
Table South America Induced Pluripotent Stem Cells Revenue Share by Type (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table South America Induced Pluripotent Stem Cells Sales Share by Application (2017-2022)
Figure Middle East and Africa Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Induced Pluripotent Stem Cells Sales Market Share by Countries in 2019
Table Middle East and Africa Induced Pluripotent Stem Cells Revenue by Countries (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure GCC Countries Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Turkey Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure Egypt Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Figure South Africa Induced Pluripotent Stem Cells Sales and Growth Rate (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales Share by Type (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Revenue by Type (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Revenue Share by Type (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table Middle East and Africa Induced Pluripotent Stem Cells Sales Share by Application (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Type (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales Market Share by Type (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Type in 2021
Table Global Induced Pluripotent Stem Cells Revenue by Type (2017-2022)
Table Global Induced Pluripotent Stem Cells Revenue Market Share by Type (2017-2022)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Type in 2019
Figure Global Human iPSCs Sales Growth Rate (2017-2022)
Figure Global Human iPSCs Price (2017-2022)
Figure Global Mouse iPSCs Sales Growth Rate (2017-2022)
Figure Global Mouse iPSCs Price (2017-2022)
Figure Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Sales Growth Rate (2017-2022)
Figure Global Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs. Price (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales by Application (2017-2022)
Table Global Induced Pluripotent Stem Cells Sales Market Share by Application (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales Market Share by Application in 2021
Figure Global Academic Research Sales Growth Rate (2017-2022)
Figure Global Drug Development and Discovery Sales Growth Rate (2017-2022)
Figure Global Toxicity Screening Sales Growth Rate (2017-2022)
Figure Global Regenerative Medicine Sales Growth Rate (2017-2022)
Figure Global Induced Pluripotent Stem Cells Sales and Growth Rate (2022-2027)
Figure Global Induced Pluripotent Stem Cells Revenue and Growth Rate (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Regions (2017-2022)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Regions (2017-2022)
Figure North America Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Europe Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Asia-Pacific Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure South America Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Figure Middle East & Africa Sales Induced Pluripotent Stem Cells Market Forecast (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Type (2022-2027)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Type (2022-2027)
Table Global Induced Pluripotent Stem Cells Sales Forecast by Application (2022-2027)
Table Global Induced Pluripotent Stem Cells Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Induced Pluripotent Stem Cells
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Fujifilm Holding Corporation (CDI)
ReproCELL
Astellas Pharma Inc
Ncardia
Cell Inspire Biotechnology
Sumitomo Dainippon Pharma
Pluricell Biotech
Fate Therapeutics, Inc
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)